Researchers evaluated the association between the use of various hormonal contraceptives and the risk for surgically treated intracranial meningioma.

Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low ...

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain tumours by as much as 500 per cent.

Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...

A woman from Fife lost part of her eyesight after developing benign tumours in her brain, which she believes are linked to a ...

A new study has found a link between progestogen medications and an increased risk of brain tumours. The study, which was published in the British Medical Journal (BMJ) by researchers at France’s ...

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a quarter of reproductive health experts prescribe ...

Researchers are developing an injection that creates a contraceptive implant in the body using an approach that could herald a new way of delivering drugs over long periods of time. Current ...

The FINANCIAL — Pfizer Inc. announced on September 24 that the company’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the United Kingdom (UK) for ...

Guests and partners in the launch of private sector Depo Medroxy Progesterone Subcutaneous( DMPA- SC) contraceptive which is self-injected. [ Jenipher Wachie, Standard] Pharmacies will now serve as ...

A new 12-month cohort study in Eastern and Northern Uganda has found that women who choose to self-inject a contraceptive called DMPA-SC experience a measurable increase in decision-making power over ...